Published in J Biol Chem on July 17, 1998
Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol (1999) 2.93
Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol (1999) 2.35
Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis. Blood (2010) 1.73
Mechanism and its regulation of tumor-induced angiogenesis. World J Gastroenterol (2003) 1.55
Inhibition of podocyte FAK protects against proteinuria and foot process effacement. J Am Soc Nephrol (2010) 1.44
Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biol (2004) 1.35
Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp Cell Res (2004) 1.16
siRNA-mediated simultaneous downregulation of uPA and its receptor inhibits angiogenesis and invasiveness triggering apoptosis in breast cancer cells. Int J Oncol (2006) 1.16
Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth. J Cell Biol (2001) 1.12
Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system. Br J Cancer (2009) 1.10
Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am J Pathol (1999) 1.08
Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism. J Cell Physiol (2009) 0.98
Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence. EMBO J (1999) 0.96
Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease. Curr Drug Targets (2011) 0.93
Amplification of the urokinase-type plasminogen activator receptor (uPAR) gene in ductal pancreatic carcinomas identifies a clinically high-risk group. Am J Pathol (2009) 0.93
The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization. Am J Physiol Cell Physiol (2008) 0.93
Endoplasmic reticulum stress and cancer. J Cancer Prev (2014) 0.92
The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells. J Biol Chem (2009) 0.88
Tyrosine phosphorylation of netrin receptors in netrin-1 signaling. Neurosignals (2008) 0.86
Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β-dependent vascular endothelial cadherin tyrosine phosphorylation. Cardiovasc Diabetol (2014) 0.84
Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes. Mol Biol Cell (2013) 0.80
Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro. Gut (2000) 0.77
Effects of ulinastatin and docetaxel on breast cancer invasion and expression of uPA, uPAR and ERK. J Exp Clin Cancer Res (2011) 0.77
Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2. Am J Physiol Heart Circ Physiol (2013) 0.76
Isolation and characterization of cell lines with reduced urokinase binding. Clin Exp Metastasis (2000) 0.75
Cloning of genomic DNA for human atrial natriuretic factor. Biochem Biophys Res Commun (1984) 6.53
International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev (2000) 6.30
The primary structure of epidermal growth factor. J Biol Chem (1972) 4.41
Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA (1994) 3.86
The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am J Physiol Endocrinol Metab (2010) 3.53
Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension (1999) 3.33
SAD phasing by combination of direct methods with the SOLVE/RESOLVE procedure. Acta Crystallogr D Biol Crystallogr (2004) 3.07
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature (1995) 3.06
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med (1988) 2.98
Increased expression of cyclooxygenase-2 in the renal cortex of human prorenin receptor gene-transgenic rats. Kidney Int (2006) 2.44
The structure of ribonuclease-S at 3.5 A resolution. J Biol Chem (1967) 2.33
Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation (2001) 2.14
Angiotensin-converting enzyme inhibitors. Circulation (1998) 2.10
Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem (1998) 2.10
Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet (1993) 2.09
Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest (1998) 1.90
Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. J Clin Invest (1989) 1.85
Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature (1991) 1.83
Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem (1993) 1.81
Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int (2000) 1.81
Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet (1994) 1.79
Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension (1997) 1.77
Isolation of preferentially expressed genes in the kidneys of hypertensive rats. Hypertension (1991) 1.75
Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest (1995) 1.72
Presence of baseline prehypertension and risk of incident stroke: a meta-analysis. Neurology (2011) 1.64
Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun (1989) 1.61
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A (1999) 1.60
Atrial natriuretic factor in rat hypothalamus, atria and plasma: determination by specific radioimmunoassay. Biochem Biophys Res Commun (1984) 1.57
Design of a diffractometer and flow cell system for X-ray analysis of crystalline proteins with applications to the crystal chemistry of ribonuclease-S. J Mol Biol (1967) 1.56
Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell (1999) 1.54
Significance of vascular renin for local generation of angiotensins. Hypertension (1991) 1.49
Isolation and characterization of renin-like enzymes from mouse submaxillary glands. Biochemistry (1972) 1.48
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int (2000) 1.44
Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation (2001) 1.44
Atrial natriuretic factor and hypertension. A review and metaanalysis. Am J Hypertens (1991) 1.44
Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. Circulation (1996) 1.40
Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem (2000) 1.38
Structure of rat atrial natriuretic factor precursor deduced from cDNA sequence. Nature (1984) 1.38
Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor. Biochem Biophys Res Commun (1992) 1.37
Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int (1997) 1.35
Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation (2000) 1.28
Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res (1999) 1.26
Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation (1993) 1.26
Endothelin action: Inhibition by a protein kinase C inhibitor and involvement of phosphoinositols. Biochem Biophys Res Commun (1989) 1.25
Amino acid sequence of mouse submaxillary gland renin. Proc Natl Acad Sci U S A (1982) 1.25
Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet (1988) 1.24
The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res (2001) 1.24
Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett (1992) 1.23
Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J Biol Chem (1998) 1.22
Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int (1990) 1.22
Effects of left ventricular shape and captopril therapy on exercise capacity after anterior wall acute myocardial infarction. Am J Cardiol (1989) 1.21
Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest (1998) 1.21
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury. Kidney Int (2006) 1.19
Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene (2012) 1.19
Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int (1998) 1.19
Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity. Biochem Biophys Res Commun (1984) 1.18
The structure of ribonuclease-S at 6 A resolution. J Biol Chem (1967) 1.18
Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 1.18
Ribosome-inactivating proteins from plants: more than RNA N-glycosidases? FASEB J (2001) 1.18
Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension (1999) 1.17
An electrophilic mechanism in the chymotrypsin-catalyzed hydrolysis of anilide substrates. J Am Chem Soc (1965) 1.16
Identification of phenylthiohydantoins of amino acids by thin-layer chromatography on a plastic-backed silica-gel plate. Anal Biochem (1972) 1.15
A radioimmunoassay for the direct measurement of renin in mice and its application to submaxillary gland and kidney studies. Endocrinology (1974) 1.14
Isolation and activation of inactive renin from human kidney and plasma. Plasma and renal inactive renins have different molecular weights. Hypertension (1982) 1.14
Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression. Biochem Biophys Res Commun (1991) 1.14
Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension (1998) 1.12
Chimeric mice carrying 'regional' targeted deletion of the angiotensin type 1A receptor gene. Evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells. J Clin Invest (1996) 1.11
A role for the adrenal renin-angiotensin system in the regulation of potassium-stimulated aldosterone production. Endocrinology (1985) 1.11
Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. J Clin Endocrinol Metab (2000) 1.11
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis. Mult Scler (2012) 1.10
Participation of adenosine 5'-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor. FEBS Lett (1987) 1.09
A comparison of combinatorial partitioning and linear regression for the detection of epistatic effects of the ACE I/D and PAI-1 4G/5G polymorphisms on plasma PAI-1 levels. Clin Genet (2002) 1.08
Molecular cloning of a complementary DNA to rat cyclophilin-like protein mRNA. Kidney Int (1990) 1.08
Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension (1999) 1.07
Two distinct forms of receptors for atrial natriuretic factor in bovine adrenocortical cells. Purification, ligand binding, and peptide mapping. J Biol Chem (1987) 1.07
Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension (2000) 1.07
Differential regulation of rat AT1a and AT1b receptor mRNA. Biochem Biophys Res Commun (1992) 1.07
AT1A, AT1B, and AT2 angiotensin II receptor subtype gene expression in rat brain. Neuroreport (1995) 1.07
Acute pulmonary embolism treated with tissue plasminogen activator. Lancet (1986) 1.06
Human renal renin. Complete purification and characterization. J Biol Chem (1980) 1.06
Prostaglandins and renin release: I. Stimulation of renin release from rabbit renal cortical slices by PGI2. Prostaglandins (1977) 1.06
Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape. J Am Coll Cardiol (1992) 1.06
Distribution of pathogenic Yersinia enterocolitica in China. Eur J Clin Microbiol Infect Dis (2009) 1.05
Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension (1986) 1.05
Rat atrial natriuretic factor: isolation, structure and biological activities of four major peptides. Biochem Biophys Res Commun (1984) 1.05
Prothrombotic effects of angiotensin. Adv Intern Med (2000) 1.05
Atrial natriuretic factor receptor on cultured Leydig tumor cells: ligand binding and photoaffinity labeling. Biochemistry (1986) 1.04
Immunohistochemical localization of renin in luteinizing hormone-producing cells of rat pituitary. Proc Natl Acad Sci U S A (1981) 1.04
Angiotensin II immunoreactivity coexists with renin in the juxtaglomerular granular cells of the kidney. Proc Natl Acad Sci U S A (1981) 1.04
Analysis of the evolution of angiotensin II type 1 receptor gene in mammals (mouse, rat, bovine and human). Biochem Biophys Res Commun (1992) 1.03
Vascular and tubular renin in the kidneys of mice. Histochemistry (1982) 1.03
Immunocytochemical localization of renin and kallikrein in the rat renal cortex. Kidney Int (1986) 1.03
Renin, angiotensins, and angiotensin-converting enzyme in neuroblastoma cells: evidence for intracellular formation of angiotensins. Proc Natl Acad Sci U S A (1981) 1.03
Interaction of the adaptor protein Shc and the adhesion molecule cadherin. J Biol Chem (1997) 1.03
Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells. Circ Res (1996) 1.02
Metalloprotease-dependent ErbB ligand shedding in mediating EGFR transactivation and vascular remodelling. Biochem Soc Trans (2003) 1.01